Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-18-004419)

Filing Details

Accession Number:: 0001179110-18-004419
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-16 09:21:43
Reporting Period:: 2018-03-15

Accepted Time:: 2018-03-16 09:21:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
855654	Immunogen Inc	IMGN	Pharmaceutical Preparations (2834)	042726691

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1486519	Brannon David Johnston	830 Winter Street Waltham MA 02451	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-15	10,000	$3.05	190,690	No	4	M	Direct
Common Stock	Disposition	2018-03-15	10,000	$11.53	180,690	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2018-03-15	10,000	$3.05	10,000	$3.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000	2017-07-18	2026-07-18	No	4	M	Direct

Footnotes

The transaction reported in this Form 4 was made pursuant to a 10(b)5-1 trading plan executed by the reporting person.
Weighted average price of shares sold
Exercisable in three equal installments over three years starting on the first year anniversary of the grant.